July 16, 2015 - ZOLL Announces Release of Its CPR Extract Capability

ZOLL ANNOUNCES RELEASE OF ITS CPR EXTRACT CAPABILITY

Open Design Aligns with Institute of Medicine Recommendation for a National Out-of-Hospital Cardiac Arrest Registry

July 16, 2015—CHELMSFORD, MASS.—ZOLL^® Medical Corporation, a manufacturer of medical devices and related software solutions, announced today the release of its CPR Extract capability for the ZOLL
X Series^® Monitor/Defibrillator. The CPR Extract expands the interface between the X Series and national registries by including 14 measures of CPR quality and five additional time parameters recorded during resuscitation attempts.

A new report from the Institute of Medicine, in part, recommends establishing a national registry to track out-of-hospital cardiac arrest. The report highlights that “A national responsibility exists to improve the likelihood of survival and favorable neurologic outcomes following a cardiac arrest. This will require immediate changes in cardiac arrest reporting, research, training, and treatment."

With the new CPR Extract, X Series users who participate in national efforts such as the Cardiac Arrest Registry to Enhance Survival (CARES) are able to include CPR metrics and receive important feedback on how to improve their cardiac arrest outcomes. The ZOLL CPR Extract is available to any ePCR solution that connects with the X Series.

“The extract was developed in anticipation of the desire for quality-focused customers to fully participate in national registries such as CARES,” said Jonathan A. Rennert, President of ZOLL. “Given the recent understanding that high-quality CPR contributes to improving survival, registry participation going forward is an invaluable resource to organizations serving the public.”

“In order for these out-of-hospital registries to gain traction, the flow of data needs to transcend proprietary databases,” said Greg Mears, MD, Medical Director of ZOLL. “ZOLL’s open data exchange policy means the CPR Extract capability is available to any X Series user no matter which ePCR system they presently use.”

About the X Series

The X Series combines the clinically superior therapeutic capabilities of ZOLL defibrillation, pacing, and CPR assistance with advanced monitoring parameters. Key among the X Series’ features is the unequaled ability to assist with improving CPR quality to keep oxygen-rich blood flowing. ZOLL’s proprietary See-Thru CPR^® minimizes the duration of pauses in CPR to enable rescuers to see the underlying rhythm. ZOLL’s Real CPR Help^® provides real-time CPR feedback, and a built-in sensor measures the depth, rate, and effectiveness of chest compressions.

About the CARES Registry

The CARES program is an out-of-hospital cardiac arrest registry that has the potential to serve as the recognized registry for the US. Established through a collaborative effort between Emory University and the Centers for Disease Control and Prevention (CDC), CARES was started in 2004 and has since expanded both nationally and internationally. Currently more than 800 EMS agencies and over 1,300 hospitals in 36 states representing a population footprint of 80 million people participate in the program.

About ZOLL Medical Corporation

ZOLL Medical Corporation, an Asahi Kasei Group company, develops and markets medical devices and software solutions that help advance emergency care and save lives, while increasing clinical and operational efficiencies. With products for defibrillation and monitoring, circulation and CPR feedback, data management, fluid resuscitation, therapeutic temperature management, and ventilation, ZOLL provides a comprehensive set of technologies that help clinicians, EMS and fire professionals, and lay rescuers treat victims needing resuscitation and acute critical care. For more information, visit www.zoll.com.

About Asahi Kasei

The Asahi Kasei Group is a diversified group of companies led by holding company Asahi Kasei Corp., with operations in the chemicals and fibers, homes and construction materials, electronics, and health care business sectors. Its health care operations include devices and systems for acute critical care, dialysis, therapeutic apheresis, transfusion, and manufacture of biotherapeutics, as well as pharmaceuticals, diagnostic reagents, and nutritional products. With more than 30,000 employees around the world, the Asahi Kasei Group serves customers in more than 100 countries. For more information, visit www.asahi-kasei.co.jp/asahi/en/.

Copyright © 2015 ZOLL Medical Corporation. All rights reserved. Real CPR Help, See-Thru CPR, X Series, and ZOLL are trademarks or registered trademarks of ZOLL Medical Corporation in the United States and other countries. Asahi Kasei is a registered trademark of Asahi Kasei Corporation. All product names are the property of their respective owners.